As the largest-ever collection of data from youth with autism who have high support needs, this resource will accelerate research into an understudied population.
Autism BrainNet is pleased to announce the release of genetic data for 27 new brain samples. The data release brings the total number of brain samples with available genetic data to 273.
SFARI will fund 18 meetings, with a focus on groups in the Simons Searchlight community, that bring together scientists and patient communities to share recent advancements and discuss future research directions.
SFARI is pleased to announce it will fund five projects investigating the influence of autism-associated risk genes on early neurodevelopment and links to later circuit-level functional outcomes. These awards will provide up to $3.6 million over 4 years to each team of researchers.
The Simons Foundation Autism Research Initiative (SFARI) is pleased to announce the funding of 23 projects as part of its 2024 Pilot and Pilot Progression awards. Awards from the 2024 cycle will provide over $9 million in total funding to 18 Pilot awards and 5 Pilot Progression awards.
The Simons Foundation Autism Research Initiative (SFARI) is pleased to announce the release of data collected from its Simons Sleep Project (SSP), a study aimed at accelerating research into sleep and daily behaviors in individuals with autism. The SSP engaged more than 100 adolescent participants with autism and their non-affected siblings and collected more than 3,000 nights’ worth of data.
The Simons Foundation is now accepting applications from undergraduate students to participate in its Shenoy Undergraduate Research Fellowship in Neuroscience (SURFiN) program for the 2025–2026 academic year. This program aims to spark and sustain interest in neuroscience among undergraduate students who have not had access to research opportunities.
Paul Wang has assumed the role of Senior Scientific Director, SFARI Pharmaceutical and Biotech Relations.